✦ LIBER ✦

Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?

✍ Scribed by Ronald M. Bukowski

Book ID: 107546730
Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 81 KB
Volume: 12
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-010-0082-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose interleukin-2 immunotherapy is

High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis

✍ JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Sunitinib rechallenge in metastatic rena

Sunitinib rechallenge in metastatic renal cell carcinoma patients

✍ Ivan N. Zama; Thomas E. Hutson; Paul Elson; James M. Cleary; Toni K. Choueiri; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Sunitinib-induced macrocytosis in patien

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Toni K. Choueiri; Paul Elson; Mohamad K. Khasawneh; Claudiu Cotta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

Sunitinib in metastatic renal cell carci

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

✍ Martin E. Gore; Subramanian Hariharan; Camillo Porta; Sergio Bracarda; Robert Ha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Treatment selection for patients with me

Treatment selection for patients with metastatic renal cell carcinoma

✍ Michael B. Atkins; Toni K. Choueiri; Daniel Cho; Meredith Regan; Sabina Signoret 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi